Mutations in the MECP2 gene — which typically underlie Rett syndrome — cause problems in how neurons, or nerve…
Margarida Maia, PhD
Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Margarida Maia, PhD
Blocking a small RNA molecule that helps control whether certain genes are switched on or off reactivated the healthy copy…
NTI164, a cannabis-based oil being developed by Neurotech International, may help girls with Rett syndrome communicate more easily, enjoy…
Early changes in speech, including fewer varied sounds, may signal Rett syndrome before obvious developmental delays and this may…
Into-the-nose delivery of a solution containing clinical-grade human nerve growth factor (NGF) improved cognitive and motor function in a mouse…
Researchers used tiny, magnetic spheres to deliver a gene editing toolbox into stem cells prepared from a patient’s skin sample…
TSHA-102, an experimental gene therapy for Rett syndrome, appears to be well tolerated and may be of benefit in multiple…
The first episode of “Magnolia’s Guide to Adventuring,” a documentary series that follows people with Rett syndrome and…
Taysha Gene Therapies has received the needed approval to move forward with dose escalation in its Phase 1/2 trial testing…
An injection of Taysha Gene Therapies’ experimental gene therapy TSHA-102 into the spinal canal of young mice…